fludarabine has been researched along with Genetic Diseases, X-Chromosome Linked in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, M; Chellapandian, D; Gassas, A; Krueger, J; Naqvi, A; Schechter, T; Weitzman, S | 1 |
| Hoshino, A; Ikegame, K; Imai, K; Inoue, T; Kaida, K; Kanegane, H; Morio, T; Ogawa, H; Okada, M; Soma, T; Tamaki, H; Yamashita, M | 1 |
| Coelho, R; Flagg, A; Gonzalez, BE; Hanna, R; Harrington, S; Kusick, K; Ondrejka, S; Procop, GW; Stempak, LM; Zembillas, A | 1 |
| Burroughs, LM; Carpenter, PA; Englund, J; Ochs, HD; Rawlings, DJ; Sanders, J; Scharenberg, AM; Skoda-Smith, S; Storb, R; Torgerson, TR; Woolfrey, AE | 1 |
| Abraham, A; Kasow, KA; Morales-Tirado, VM; Persons, DA; Riberdy, JM; Shurtleff, SA; Wichlan, D | 1 |
1 review(s) available for fludarabine and Genetic Diseases, X-Chromosome Linked
| Article | Year |
|---|---|
Mycobacterium genavense-induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature.
Topics: Abdomen; Adolescent; Alemtuzumab; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Antibodies, Monoclonal, Humanized; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Cyclosporine; Diabetes Mellitus, Type 1; Diarrhea; Genetic Diseases, X-Linked; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytes; Humans; Immune System Diseases; Immunosuppressive Agents; Lymph Nodes; Male; Melphalan; Mycobacterium Infections, Nontuberculous; Mycophenolic Acid; Nontuberculous Mycobacteria; Photopheresis; Polymerase Chain Reaction; Transplantation Conditioning; Vidarabine | 2017 |
4 other study(ies) available for fludarabine and Genetic Diseases, X-Chromosome Linked
| Article | Year |
|---|---|
Successful Allogeneic Hematopoietic Stem Cell Transplantation in XIAP Deficiency Using Reduced-Intensity Conditioning.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Child, Preschool; Genetic Diseases, X-Linked; Hematopoietic Stem Cell Transplantation; Humans; Lymphoproliferative Disorders; Male; Melphalan; Myeloablative Agonists; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2016 |
Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity.
Topics: Adult; Agammaglobulinemia; Antilymphocyte Serum; Cyclophosphamide; Genetic Diseases, X-Linked; Humans; Immunity, Humoral; Immunoglobulin A; Immunoglobulin M; Male; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2016 |
Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Topics: Adolescent; Cell Separation; Child; Cyclosporine; Flow Cytometry; Forkhead Transcription Factors; Genetic Diseases, X-Linked; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Infant; Male; Mycophenolic Acid; Myeloablative Agonists; Reverse Transcriptase Polymerase Chain Reaction; Syndrome; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2010 |
Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Cell Survival; Forkhead Transcription Factors; Genetic Diseases, X-Linked; Graft Enhancement, Immunologic; Graft Survival; Humans; Immunologic Deficiency Syndromes; Infant; Interleukin-2 Receptor alpha Subunit; Lymphocyte Depletion; Male; Melphalan; Point Mutation; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Thiotepa; Thymus Gland; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2011 |